Insulet
PODD
#993
Rank
C$28.21 B
Marketcap
$402.23
Share price
-1.90%
Change (1 day)
54.82%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.45. In 2022 the company made an earnings per share (EPS) of $0.09956 a decrease over its 2021 EPS that were of $0.33.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322231.67%
2022$0.09956-69.57%
2021$0.33109.09%
2020$0.16-38.89%
2019$0.26200%
2018$0.08534-113.04%
2017-$0.65-9.8%
2016-$0.73-60.77%
2015-$1.8539.78%
2014-$1.3212.05%
2013-$1.18-23.15%
2012-$1.5410.2%
2011-$1.39-36.36%
2010-$2.19-36.63%
2009-$3.46-29.36%
2008-$4.89-86.74%
2007-$36.90-64.04%
2006-$102.62122.23%
2005-$46.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.87-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.59-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.39-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.03 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.23 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.87 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.72 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA